Subcarinal ventilation-assisted Y-shaped stent insertion under local anesthesia for patients with complex tracheobronchial stenosis: initial clinical experience

Fu, Yu Fei; Wei, Ning; Zhang, Ke; Xu, Hao

doi:10.5152/dir.2014.13498

Cited by 11 publications

(5 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although surgical resection is still the best treatment for NSCLC, most patients were diagnosed at the advanced stage and were not candidates for surgical treatment [10][11][12]. The first pass effect is the mechanism of TAI.…”

Section: Discussionmentioning

confidence: 99%

Transcatheter arterial chemical infusion for advanced non-small-cell lung cancer: long-term outcome and predictor of survival

Wei

et al. 2016

Radiol med

Self Cite

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Transcatheter arterial chemical infusion for advanced non-small-cell lung cancer: long-term outcome and predictor of survival

Wei

et al. 2016

Radiol med

Self Cite

View full text Add to dashboard Cite

show abstract

“…Many retrospective studies have considered the survival effects of airway stent applications. Survival has been reported to be 109‐181 days with a Y‐type silicon stent and 116‐217 days with Y‐shaped SEMS . In our study, survival in the silicon and SEMS groups were 164.51 ± 38.83 days and 254.45 ± 103.32 days, respectively ( P > .05).…”

Section: Discussionmentioning

confidence: 45%

“…Survival has been reported to be 109-181 days with a Y-type silicon stent and 116-217 days with Y-shaped SEMS. 17,[25][26][27][28][29] In our study, survival in the silicon and SEMS groups were 164.51 ± 38.83 days and 254.45 ± 103.32 days, respectively (P > .05).…”

Section: Discussionmentioning

confidence: 83%

Comparison of silicon and metallic bifurcated stents in patients with malignant airway lesions

Sökücü

Özdemir

Önür

et al. 2019

Clinical Respiratory J

View full text Add to dashboard Cite

Introduction and objective Silicon and metallic are two types of stents in use. In this study, we compared complications and long‐term survival among patients who received silicon or fully covered, bifurcated self‐expandable metallic stents (SEMS) for a malignant tracheobronchial obstruction and/or tracheo/bronchial oesophageal fistulas. Methods Patients in whom Y‐shaped stents were used from January 2013 to June 2017 in our interventional pulmonology unit were evaluated retrospectively from patient files. Results Of the 47 patients, 30 (23 males, 76.7%) were in the silicon stent group and 17 (14 males, 82.4%) were in the covered SEMS group. No differences between the groups were detected in ECOG status, pathological properties of the disease, radiotherapy or chemotherapy history before the procedure, symptoms at presentation, or comorbidities. The most common symptom was dyspnoea (96.7% and 100%), and the most common comorbidity was chronic obstructive pulmonary disease (26.7% and 23.5%). A total of 20 complications (42.6%) were seen, with no significant difference between the groups (silicon, 40%; SEMS, 47.1%; P = . 62). Mean survival was 164.51 ± 38.83 days for the silicon stent group and 254.45 ± 103.32 days for the SEMS group (P = .588). No differences were observed in 30‐, 90‐ or 180‐day mortality between the two groups (P = .966, .846 and .534, respectively). Conclusions No significant differences in symptom palliation, insertion safety, complication rate or survival were detected between the two types of stent.

show abstract

“…Two case series published in 2006 and 2008 have demonstrated good feasibility and high success rates. Overall, to date, 12 case series (including 370 patients) describing the use of tracheobronchial SEMS have been published, with similar success rates, efficacy and median survival as the silicone stents 6,19,28–37 . A review of the insertion technique shows that despite the Y SEMS advantage, not requiring the use of a rigid bronchoscopy, its limitation is a wide delivery system that requires a large caliber deployment conductor.…”

Section: Discussionmentioning

confidence: 99%

Placement of self‐expanding metallic tracheobronchial Y stent with laryngeal mask airway using conscious sedation under fluoroscopic guidance

et al. 2020

View full text Add to dashboard Cite

Background Central airway obstruction and fistula are treated with a tracheobronchial Y stent. In the currently used self‐expandable metal Y stents, the delivery system is 8 mm in diameter and requires either a 9 mm tracheal tube or rigid bronchoscope to enable airway control during insertion. In this study we present a novel technique of laryngeal mask airway (LMA) assisted Y stent insertion, enabling airway control during deployment of the Y stent. Methods All procedures using LMA in assisting Y stent insertions between 2014–2020 were reviewed. Data collected included demographics, clinical diagnosis and disease characteristics, indication, procedural success rates, clinical outcome and survival. Results A total of 10 patients with a median age of 61.5 years (range 37–73) underwent LMA assisted Y stent insertion. Indications for stent insertion were malignant disease with central airway obstruction or fistula. In all cases airway patency was achieved leading to improvement of symptoms and performance status. No procedural complications were reported. The median survival was 4.5 weeks (range: 2–26). Conclusions LMA assisted Y stent insertion enables airway control during the procedure. In comparison to silicone Y stent insertion, the procedure is less cumbersome, shorter in duration and does not require the use of general anesthesia or rigid bronchoscopy. Key points Significant findings of the study LMA assisted Y stent insertion enables airway control during the implantation of metallic self‐expanding Y stent. The procedure does not require the use of general anesthesia or rigid bronchoscopy. What this study adds In this study we present the technique and outcomes of LMA assisted Y stent insertion. This method of Y stent insertion provides an additional treatment option for patients with central airway obstruction and fistula.

show abstract

Subcarinal ventilation-assisted Y-shaped stent insertion under local anesthesia for patients with complex tracheobronchial stenosis: initial clinical experience

Cited by 11 publications

References 7 publications

Transcatheter arterial chemical infusion for advanced non-small-cell lung cancer: long-term outcome and predictor of survival

Transcatheter arterial chemical infusion for advanced non-small-cell lung cancer: long-term outcome and predictor of survival

Comparison of silicon and metallic bifurcated stents in patients with malignant airway lesions

Placement of self‐expanding metallic tracheobronchial Y stent with laryngeal mask airway using conscious sedation under fluoroscopic guidance

Contact Info

Product

Resources

About